OSN New York Retina 2023 Meeting

CME INFORMATION

Evaluations and CME Certificates

Online evaluations will be available through December 13, 2022 (please email evals@HealioLive.com if you need your login credentials). Please email evals@HealioLive.com if you need assistance with this year’s credits or cme@VindicoMedEd.com if you need a certificate from a previous year.

Target Audience: General Sessions

The intended audience for this activity is retina specialists and other health care professionals involved in the management of patients with retinal disease.

Learning Objectives: General Sessions

Upon successful completion of this activity, participants should be better able to:

Assess advances in vitreoretinal surgery, including the management of vitreoretinopathy, retinal detachment, refractory macular holes, sickle cell retinopathy, epiretinal membranes, as well as the use of the port delivery system.
Examine case presentations specific to the surgical management of retinal diseases and conditions.
Evaluate practice patterns for diabetic eye disease, including the use of current and emerging medical therapies, imaging and OCT, and DRCR studies.
Examine case presentations specific to the care of patients with diabetic eye disease.
Explore the various issues that retina specialists face in managing exudative age-related macular degeneration, including the use of therapies with a longer duration of action, emerging therapies, gene therapy, as well as when to stop treatment.
Describe new clinical evidence regarding the pathophysiology of geographic atrophy, use of imaging to track its progression, findings from phase 3 clinical trials, and appropriate patient selection for its treatment.
Examine case presentations specific to the management of age-related macular degeneration.
Assess current medical retina issues and their management, including myopic degeneration, chronic central serous chorioretinopathy, mimics of age-related macular degeneration, and retinal vascular abnormalities.
Examine case presentations specific to the medical management of retinal diseases and conditions.

This continuing education activity is provided by

Accreditation: In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation: Vindico Medical Education designates this live activity for a maximum of 13 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty/Planner Disclosure Policy: Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest will be mitigated prior to the commencement of the activity.

All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational uses of any products/devices.

Notice: Faculty, topics, program schedule and credit hours are subject to change. Audiotaping or videotaping is prohibited without written permission from the program director and the Office of Medical Affairs and Compliance.